Celsius (NASDAQ:CELH) Price Target Raised to $40.00

Celsius (NASDAQ:CELH) had its target price boosted by research analysts at Needham & Company LLC from $38.00 to $40.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price target would suggest a potential upside of 27.51% from the stock’s current price.

A number of other brokerages have also recently issued reports on CELH. UBS Group decreased their target price on Celsius from $45.00 to $39.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Piper Sandler dropped their price target on Celsius from $47.00 to $33.00 and set an “overweight” rating on the stock in a research note on Thursday, January 23rd. JPMorgan Chase & Co. assumed coverage on shares of Celsius in a research note on Thursday, December 12th. They set an “overweight” rating and a $37.00 price objective for the company. TD Cowen downgraded shares of Celsius from a “buy” rating to a “hold” rating and dropped their target price for the stock from $40.00 to $29.00 in a research report on Wednesday, January 22nd. Finally, Stifel Nicolaus reduced their price target on shares of Celsius from $45.00 to $37.00 and set a “buy” rating for the company in a research report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $47.78.

Celsius Stock Down 3.8 %

Shares of CELH stock opened at $31.37 on Tuesday. The stock has a 50-day simple moving average of $26.02 and a 200 day simple moving average of $30.18. Celsius has a fifty-two week low of $21.10 and a fifty-two week high of $99.62. The stock has a market capitalization of $7.37 billion, a P/E ratio of 71.30, a P/E/G ratio of 2.90 and a beta of 1.78.

Celsius (NASDAQ:CELH) last released its earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.03. The business had revenue of $332.20 million for the quarter, compared to the consensus estimate of $326.07 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. On average, sell-side analysts anticipate that Celsius will post 0.89 earnings per share for the current year.

Insider Transactions at Celsius

In other news, major shareholder William H. Milmoe sold 65,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $31.15, for a total transaction of $2,024,750.00. Following the completion of the sale, the insider now owns 261,245 shares in the company, valued at approximately $8,137,781.75. This represents a 19.92 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.20% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Celsius

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. HM Payson & Co. lifted its stake in shares of Celsius by 122.2% in the fourth quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock worth $26,000 after buying an additional 550 shares during the last quarter. Signaturefd LLC grew its position in shares of Celsius by 48.3% in the third quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock valued at $36,000 after purchasing an additional 378 shares during the last quarter. S.A. Mason LLC increased its stake in shares of Celsius by 100.0% in the fourth quarter. S.A. Mason LLC now owns 1,400 shares of the company’s stock worth $37,000 after purchasing an additional 700 shares during the period. Activest Wealth Management bought a new position in shares of Celsius in the third quarter worth about $39,000. Finally, Blue Trust Inc. lifted its position in shares of Celsius by 69.0% during the 3rd quarter. Blue Trust Inc. now owns 1,345 shares of the company’s stock worth $42,000 after purchasing an additional 549 shares during the last quarter. 60.95% of the stock is currently owned by institutional investors and hedge funds.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.